What is Nephrology Associates?
Operating for over four decades, Nephrology Associates functions as a premier group of internists specializing in the diagnosis and management of complex kidney diseases. The practice provides a comprehensive suite of services, ranging from the treatment of hypertension and electrolyte imbalances to the management of chronic peritoneal and hemodialysis. By maintaining a strong academic affiliation with The Warren Alpert Medical School of Brown University, the firm bridges the gap between clinical research and patient-centered care. Their expertise in renal transplantation evaluation and post-surgical management positions them as a critical node in the regional healthcare ecosystem, ensuring that patients with chronic conditions receive high-quality, compassionate medical intervention.
How much funding has Nephrology Associates raised?
Nephrology Associates has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Nephrology Associates
PPP
Public-Private Partnership
What's next for Nephrology Associates?
The influx of capital from this late-stage funding round provides Nephrology Associates with the necessary resources to scale its specialized care models and integrate advanced diagnostic technologies. As the demand for chronic kidney disease management continues to rise, the firm is well-positioned to optimize its operational efficiency and expand its footprint in renal transplantation support. Future strategic initiatives will likely focus on enhancing the integration of dialysis services and deepening its academic partnerships to remain at the forefront of nephrological innovation. By leveraging this financial backing, the organization aims to sustain its long-term growth trajectory while maintaining the high standards of clinical excellence that have defined its four-decade history.
See full Nephrology Associates company page
